Showing results (1391-1400 of 1,405) with videos related to
Sort By:
Pageof 141
BMC Health Services Research|May 20, 2021
Understanding what matters most to patients in acute care in seven countries, using the flash mob study designEva S van den Ende, Bo Schouten, Marjolein N T Kremers, et al.Biomaterials|April 7, 2023
Tail nerve electrical stimulation promoted the efficiency of transplanted spinal cord-like tissue as a neuronal relay to repair the motor function of rats with transected spinal cord injuryBi-Qin Lai, Rong-Jie Wu, Wei-Tao Han, et al.Theranostics|July 14, 2022
Blockade of phosphotyrosine pathways suggesting SH2 superbinder as a novel therapy for pulmonary fibrosisMeng Wang, An-Dong Liu, Qian Niu, et al.Signal Transduction and Targeted Therapy|September 15, 2025
Anlotinib plus sintilimab as first-line treatment for patients with advanced colorectal cancer (APICAL-CRC): an open-label, single-arm, phase II trialZhan Wang, Bao-Dong Qin, Chen-Yang Ye, et al.The Journal of Pathology|July 12, 2017
Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virusWen-Chun Liu, I-Chin Wu, Yen-Chien Lee, et al.Expert Review of Medical Devices|October 6, 2022
Comparison of the supraglottic airway device BlockBusterTM and laryngeal mask airway Supreme in anaesthetised, paralyzed adult patients: a multicenter randomized controlled trialXue Gao, Ju-Hui Liu, Chun-Mei Chen, et al.Molecular Biology and Evolution|November 1, 2017
Out of Southern East Asia of the Brown Rat Revealed by Large-Scale Genome SequencingLin Zeng, Chen Ming, Yan Li, et al.BMJ Open|January 27, 2025
Chinese herbal formula Tongxie Yaofang granules for diarrhoea-predominant irritable bowel syndrome: a randomised, double-blind, placebo-controlled, phase II trialShi-Bing Liang, Hong-Jie Cheng, Qiao-Yan Zhang, et al.Leukemia|October 20, 2020
Donor-derived CD19 CAR-T cell therapy of relapse of CD19-positive B-ALL post allotransplantCheng Zhang, Xiao-Qi Wang, Rong-Li Zhang, et al.Cell Metabolism|January 18, 2024
Lysine acetyltransferase 6A maintains CD4<sup>+</sup> T cell response via epigenetic reprogramming of glucose metabolism in autoimmunityJia-Yao Fu, Shi-Jia Huang, Bao-Li Wang, et al.Pageof 141